Dr. Robert M. Grant is a physician specialized in internal medicine, pulmonary medicine, and HIV medicine. He has more than 30 years of experience with research and clinical practice in sexual health and pulmonary medicine. He pioneered the concept of pre-exposure prophylaxis, or PrEP, for HIV prevention by leading the iPrEx trials that led to FDA approvals and transformed clinical practice globally - an achievement for which he was recognized by Time Magazine as one of the 100 most influential people in the world in 2012.After a deep personal loss in 2014, he pivoted to face the challenges of human connection more directly through psychotherapy. He completed a certificate in Psychedelic-Assisted Therapies and Research from the California Institute of Integral Studies in 2016, and trained in ketamine assisted psychotherapy at the KRIYA Institute in 2017. He is a a board member of the American Society of Ketamine Physicians. He has trained in psychotherapy modalities including Internal Family Systems (as a fully certified IFS Therapist) and Eye Movement Desensitization and Reprocessing. He has provided ketamine assisted psychotherapy in San Francisco since late 2017. He serves as an investigator for an FDA-approved MDMA trial at UCSF and has assisted for FDA-approved psilocybin trials for people living with HIV.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related